0,958  0,001  Dopamine D1 antagonist
0,876  0,003  Muscle relaxant
0,840  0,003  Dopamine antagonist
0,834  0,003  5 Hydroxytryptamine release stimulant
0,822  0,003  Skeletal muscle relaxant
0,819  0,003  Dopamine D2 antagonist
0,807  0,005  Respiratory analeptic
0,802  0,002  Dopamine D2 agonist
0,781  0,003  Alpha 2 adrenoreceptor antagonist
0,785  0,013  Caspase 9 stimulant
0,760  0,003  Dopamine agonist
0,736  0,004  Alpha adrenoreceptor antagonist
0,688  0,004  Cardiodepressant
0,676  0,003  Antiparkinsonian, rigidity relieving
0,673  0,003  Alpha 2a adrenoreceptor antagonist
0,674  0,005  Hypoxia-inducible factor 1 alpha inhibitor
0,682  0,023  Transcription factor NF kappa B inhibitor
0,662  0,008  Spasmolytic
0,650  0,010  Analeptic
0,635  0,003  Dopamine D5 antagonist
0,632  0,003  Alpha 2b adrenoreceptor antagonist
0,630  0,004  5 Hydroxytryptamine 7 antagonist
0,622  0,004  Sigma receptor agonist
0,629  0,014  Antiparkinsonian
0,632  0,025  CYP3A4 substrate
0,606  0,009  CYP2C19 inhibitor
0,622  0,027  Antineoplastic (lung cancer)
0,597  0,004  5 Hydroxytryptamine 2 antagonist
0,591  0,007  CYP2D6 inhibitor
0,611  0,047  Apoptosis agonist
0,587  0,025  15-Lipoxygenase inhibitor
0,565  0,004  5 Hydroxytryptamine 2A antagonist
0,560  0,004  5 Hydroxytryptamine 1A antagonist
0,558  0,003  Dopamine D3 antagonist
0,550  0,005  5 Hydroxytryptamine antagonist
0,559  0,017  CYP1A2 substrate
0,545  0,003  Alpha 2c adrenoreceptor antagonist
0,561  0,023  Prostate cancer treatment
0,554  0,027  CYP2C9 substrate
0,532  0,005  Male reproductive disfunction treatment
0,526  0,004  5 Hydroxytryptamine 1 antagonist
0,539  0,033  Antileukemic
0,511  0,007  Genotoxic
0,503  0,005  Erectile dysfunction treatment
0,502  0,006  Cyclic AMP phosphodiesterase inhibitor
0,513  0,019  Caspase 3 stimulant
0,516  0,025  Antidepressant
0,505  0,035  Antineoplastic (colorectal cancer)
0,474  0,004  Tyrosine 3 hydroxylase inhibitor
0,500  0,033  Antineoplastic (colon cancer)
0,477  0,014  Vasodilator
0,512  0,051  Antineoplastic (breast cancer)
0,488  0,027  CYP2D6 substrate
0,464  0,004  Antitussive
0,462  0,018  DNA damaging
0,476  0,034  Mood disorders treatment
0,449  0,009  Antineoplastic (squamous cell carcinoma)
0,440  0,005  Alpha 1 adrenoreceptor antagonist
0,440  0,006  Pneumotoxic
0,455  0,025  UGT1A9 substrate
0,454  0,030  Hepatic disorders treatment
0,464  0,043  Histamine release inhibitor
0,430  0,017  Antineoplastic enhancer
0,422  0,011  Tubulin antagonist
0,428  0,017  Sedative
0,424  0,014  P-glycoprotein inhibitor
0,447  0,041  Vasodilator, peripheral
0,437  0,036  Antihypercholesterolemic
0,413  0,018  Pyruvate kinase inhibitor
0,390  0,006  Neurotrophic factor enhancer
0,395  0,013  Antiseptic
0,385  0,011  Topoisomerase II inhibitor
0,395  0,024  Antimitotic
0,367  0,007  Acetylcholine M1 receptor antagonist
0,365  0,010  Antiadrenergic
0,380  0,026  Psychostimulant
0,388  0,035  CYP3A4 inhibitor
0,359  0,011  5 Hydroxytryptamine 2B antagonist
0,434  0,088  Antineoplastic (solid tumors)
0,351  0,010  5 Hydroxytryptamine 1E antagonist
0,403  0,066  Prostaglandin dehydrogenase inhibitor
0,347  0,010  Adrenaline antagonist
0,354  0,018  Hepatoprotectant
0,337  0,003  Restless leg syndrome treatment
0,338  0,007  Alpha 1a adrenoreceptor antagonist
0,340  0,011  Acetylcholine antagonist
0,373  0,045  Cardioprotectant
0,338  0,011  Cholinergic antagonist
0,324  0,005  LDLR expression enhancer
0,367  0,048  Antineoplastic (melanoma)
0,359  0,041  Antineoplastic (non-small cell lung cancer)
0,366  0,050  12-Lipoxygenase inhibitor
0,363  0,051  Antipsychotic
0,338  0,041  Tumour necrosis factor alpha release inhibitor
0,344  0,047  Antineoplastic (glioma)
0,314  0,020  Antineoplastic (carcinoma)
0,338  0,044  Antipyretic
0,297  0,004  5 Hydroxytryptamine 5A antagonist
0,336  0,043  Antineoplastic (small cell lung cancer)
0,300  0,011  Topoisomerase I inhibitor
0,324  0,041  Antineoplastic (glioblastoma multiforme)
0,333  0,051  Antioxidant
0,321  0,041  Mutagenic
0,291  0,013  Toxic, respiratory center
0,323  0,046  Free radical scavenger
0,293  0,018  Antiparkinsonian, tremor relieving
0,277  0,004  5 Hydroxytryptamine 5 antagonist
0,317  0,044  Antineoplastic (liver cancer)
0,332  0,062  Antineoplastic (ovarian cancer)
0,273  0,004  Antineoplastic alkaloid
0,326  0,062  Antineoplastic (brain cancer)
0,299  0,035  Abortion inducer
0,297  0,034  Anesthetic general
0,284  0,021  Cholinergic
0,319  0,059  CYP2C19 substrate
0,261  0,006  Opioid kappa receptor antagonist
0,323  0,070  Calcium channel activator
0,300  0,050  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,264  0,018  Acetylcholinesterase inhibitor
0,259  0,015  Alkylator
0,256  0,014  Acetylcholine muscarinic antagonist
0,246  0,004  Prolactin inhibitor
0,243  0,009  Dopamine D4 antagonist
0,287  0,054  Antineoplastic (lymphoma)
0,237  0,004  Antiviral (Papilloma)
0,288  0,061  Antineoplastic (cervical cancer)
0,242  0,018  Uterine stimulant
0,262  0,038  Antialcoholic
0,240  0,020  Antiviral (Hepatitis B)
0,304  0,084  Vasodilator, coronary
0,221  0,002  Dopamine D1 agonist
0,285  0,070  Antihypoxic
0,263  0,054  Dependence treatment
0,219  0,013  Alpha 1b adrenoreceptor antagonist
0,216  0,011  Acetylcholine nicotinic antagonist
0,225  0,020  DNA intercalator
0,289  0,093  Antihypertensive
0,262  0,067  Dyrk kinase inhibitor
0,227  0,033  Liver fibrosis treatment
0,206  0,013  Breast cancer-resistant protein inhibitor
0,218  0,028  CDC-like kinase 1 inhibitor
0,297  0,107  Stroke treatment
0,192  0,005  Alpha 2 adrenoreceptor agonist
0,205  0,019  Expectorant
0,194  0,009  Alpha adrenoreceptor agonist
0,185  0,005  Phosphodiesterase XI inhibitor
0,185  0,005  Phosphodiesterase 11A inhibitor
0,264  0,084  Radioprotector
0,188  0,011  5 Hydroxytryptamine 1F antagonist
0,218  0,042  UGT1A3 substrate
0,233  0,060  Antiarrhythmic
0,185  0,015  Calcium antagonist
0,185  0,017  Topoisomerase II alpha inhibitor
0,226  0,059  Nitric oxide antagonist
0,178  0,011  CDC-like kinase 3 inhibitor
0,174  0,008  Alpha tubulin antagonist
0,180  0,018  Opioid antagonist
0,203  0,041  Lipid peroxidase inhibitor
0,165  0,011  Neuronal nicotinic receptor antagonist
0,211  0,057  UGT2B7 substrate
0,234  0,081  NOS2 expression inhibitor
0,162  0,011  Beta tubulin antagonist
0,186  0,036  Anesthetic local
0,163  0,015  Opioid mu receptor antagonist
0,157  0,010  Phosphodiesterase V inhibitor
0,156  0,014  Alpha 1d adrenoreceptor antagonist
0,228  0,086  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,207  0,066  UDP-glucuronosyltransferase substrate
0,228  0,091  Antineoplastic (renal cancer)
0,262  0,128  Antiprotozoal (Plasmodium)
0,143  0,010  Alpha 1 adrenoreceptor agonist
0,143  0,012  Phosphodiesterase 5A inhibitor
0,241  0,110  Antiischemic
0,172  0,043  M18 aspartyl aminopeptidase inhibitor
0,180  0,052  Antiischemic, cerebral
0,176  0,049  Antidiarrheal
0,137  0,014  Female sexual dysfunction treatment
0,175  0,052  Carcinogenic, group 1
0,151  0,030  Constipation treatment
0,141  0,021  Opioid delta receptor antagonist
0,198  0,079  Sensitization
0,258  0,142  Immunosuppressant
0,172  0,057  UGT2B9 substrate
0,118  0,003  Prolactin release inhibitor
0,192  0,078  UGT1A1 substrate
0,221  0,108  Antineoplastic (bladder cancer)
0,206  0,096  Antiprotozoal (Leishmania)
0,172  0,063  Catenin beta inhibitor
0,174  0,065  ATPase inhibitor
0,187  0,078  Platelet adhesion inhibitor
0,178  0,072  Chemopreventive
0,224  0,118  Antineoplastic (multiple myeloma)
0,131  0,025  5 Hydroxytryptamine agonist
0,165  0,060  Heat shock protein 90 antagonist
0,202  0,098  Cytostatic
0,125  0,023  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,154  0,053  Psychosexual dysfunction treatment
0,118  0,017  5 Hydroxytryptamine 1B antagonist
0,110  0,011  Opioid mu receptor agonist
0,228  0,130  Bone diseases treatment
0,104  0,009  Opioid kappa receptor agonist
0,128  0,033  5 Hydroxytryptamine 2C antagonist
0,117  0,024  Analgesic, opioid
0,218  0,125  Anxiolytic
0,104  0,011  Nicotinic receptor alpha7 subunit antagonist
0,114  0,021  Nicotinic alpha4beta2 receptor antagonist
0,254  0,162  TNF expression inhibitor
0,243  0,153  Cognition disorders treatment
0,104  0,018  Dopamine uptake inhibitor
0,163  0,077  UGT2B10 substrate
0,130  0,045  Choleretic
0,173  0,091  Cytotoxic
0,153  0,070  Antidote
0,133  0,055  Antiprotozoal (Amoeba)
0,088  0,010  5 Hydroxytryptamine 7 agonist
0,094  0,017  5 Hydroxytryptamine 2A agonist
0,200  0,123  DNA synthesis inhibitor
0,186  0,110  Antiamyloidogenic
0,102  0,027  Acetylcholine M4 receptor antagonist
0,090  0,016  Opioid agonist
0,081  0,007  Factor III inhibitor
0,152  0,079  Melanin inhibitor
0,084  0,011  5 Hydroxytryptamine 4 antagonist
0,243  0,171  Antiprotozoal
0,119  0,048  Butyrylcholinesterase inhibitor
0,097  0,027  Narcotic antagonist
0,173  0,105  Antihypertriglyceridemic
0,137  0,069  Anesthetic
0,105  0,039  Phosphodiesterase I inhibitor
0,187  0,121  Acute neurologic disorders treatment
0,084  0,018  Heat shock protein 90 beta antagonist
0,111  0,045  Estrogen receptor beta antagonist
0,080  0,015  5 Hydroxytryptamine 2 agonist
0,068  0,005  Dopamine autoreceptor agonist
0,195  0,134  Antineoplastic (sarcoma)
0,100  0,039  ATPase (Vacuolar H+) inhibitor
0,075  0,015  5 Hydroxytryptamine 1B agonist
0,079  0,020  Sigma receptor antagonist
0,087  0,029  Antitreponemal
0,082  0,025  Glutamate (mGluR7) antagonist
0,111  0,054  Toll-Like receptor 4 antagonist
0,085  0,029  5 Hydroxytryptamine 1D antagonist
0,125  0,069  Papain-like protease (SARS coronavirus) inhibitor
0,116  0,062  Estrogen antagonist
0,070  0,017  Ryanodine receptor antagonist
0,085  0,032  HIV-1 integrase (3'-Processing) inhibitor
0,085  0,034  HIV-1 integrase inhibitor
0,072  0,022  5 Hydroxytryptamine 1A agonist
0,164  0,114  Teratogen
0,080  0,031  HIV-1 integrase (Strand Transfer) inhibitor
0,100  0,052  Phosphodiesterase 6D inhibitor
0,108  0,061  DOPA decarboxylase inhibitor
0,059  0,011  5 Hydroxytryptamine 3B antagonist
0,121  0,077  Antismoking
0,141  0,097  Heat shock protein 90 alpha antagonist
0,186  0,142  Proliferative diseases treatment
0,055  0,013  Phosphodiesterase 6C inhibitor
0,075  0,033  Acetylcholine M2 receptor antagonist
0,153  0,111  Phobic disorders treatment
0,184  0,143  Antineoplastic (pancreatic cancer)
0,063  0,023  Nicotinic alpha3beta2 receptor antagonist
0,124  0,084  Antifungal enhancer
0,179  0,140  Cardiotonic
0,060  0,021  Nicotinic receptor alpha4 subunit antagonist
0,151  0,113  Antimigraine
0,147  0,110  Antineoplastic (gastric cancer)
0,103  0,066  AMP-activated protein kinase stimulant
0,065  0,030  5 Hydroxytryptamine 1 agonist
0,109  0,076  Microtubule formation inhibitor
0,058  0,026  Dopamine transporter inhibitor
0,065  0,035  Acetylcholine M3 receptor antagonist
0,046  0,016  Vesicle monoamine transporter inhibitor
0,198  0,170  FMO3 substrate
0,078  0,051  Estrogen receptor alpha antagonist
0,192  0,167  AR expression inhibitor
0,046  0,022  Dopamine D3 agonist
0,038  0,013  Phosphodiesterase 6B inhibitor
0,146  0,122  Embryotoxic
0,071  0,050  Calcium channel L-type blocker
0,125  0,104  Antiviral (Herpes)
0,106  0,086  Sphingosine 1-phosphate receptor 2 agonist
0,170  0,151  Antiprotozoal (Trypanosoma)
0,060  0,041  Acetylcholine M5 receptor antagonist
0,223  0,204  Antibacterial
0,073  0,056  Phosphodiesterase VI inhibitor
0,143  0,127  Antineoplastic (bone cancer)
0,027  0,011  Phosphodiesterase 6H inhibitor
0,027  0,011  Phosphodiesterase 6G inhibitor
0,196  0,182  Antithrombotic
0,049  0,035  Topoisomerase II beta inhibitor
0,081  0,067  mTOR complex 2 inhibitor
0,036  0,023  Opioid delta receptor agonist
0,183  0,169  UGT2B4 substrate
0,030  0,017  Endothelin receptor antagonist
0,166  0,154  Hypoglycemic
0,023  0,011  Endothelin B receptor antagonist
0,074  0,062  Antineoplastic antibiotic
0,042  0,034  5 Hydroxytryptamine 2C agonist
0,130  0,122  Heat shock protein 70 antagonist
0,131  0,125  Amyloid beta aggregation inhibitor
0,146  0,140  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,085  0,080  Antiviral (Hepatitis A)
0,063  0,058  Histidine decarboxylase inhibitor
0,019  0,017  Endothelin A receptor antagonist
0,112  0,110  Antineoplastic (uterine cancer)
0,091  0,089  Cystathionine beta-synthase inhibitor
0,105  0,104  NADPH oxidase inhibitor
0,165  0,163  RNA-directed DNA polymerase inhibitor

